Home › Cancro del polmone non a piccole cellule › Illinois › Arlington Heights
Studi clinici su Cancro del polmone non a piccole cellule a Arlington Heights, IL
12 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Arlington Heights e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- Advocate Good Shepherd Hospital, Barrington · a 9 mi di distanza
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
In reclutamentoFase 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
In reclutamentoFase 3
- Illinois Cancer Specialists, Arlington Heights
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
In reclutamentoStudio osservazionale
- Northwest Oncology & Hematology, Elk Grove Village · a 6 mi di distanza
An External Control Arm Study in Non-Small Cell Lung Cancer
In reclutamentoStudio osservazionale
- Northwest Oncology and Hematology, Rolling Meadows · a 2 mi di distanza
- Northwest Oncology and Hematology, Elk Grove · a 6 mi di distanza
- Northwest Oncology and Hematology, Hoffman Estates · a 6 mi di distanza
- e altri 1
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
In reclutamentoFase 2/3
- Local Institution - 007-883-A, Arlington Heights
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
In reclutamentoFase 3
- Illinois Cancer Specialists, Arlington Heights
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
In reclutamentoFase 3
- Northwest Oncology & Hematology, Barrington · a 9 mi di distanza
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Advocate Good Shepherd Hospital, Barrington · a 9 mi di distanza
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Advocate Good Shepherd Hospital, Barrington · a 9 mi di distanza
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2/3
- Advocate Good Shepherd Hospital, Barrington · a 9 mi di distanza
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Advocate Good Shepherd Hospital, Barrington · a 9 mi di distanza
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Altri studi a Arlington Heights
- Cancro colorettale12 studi
- Cancro ai polmoni9 studi
- Cancro al seno7 studi
- Insufficienza cardiaca7 studi
- Cancro metastatico6 studi
- Colite ulcerosa6 studi
- Cancro del colon6 studi
- Cancro ovarico5 studi
- Obesità5 studi
- Sovrappeso5 studi
- Cancro alla prostata3 studi
- Disturbi della pelle3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.